Use of GLP-1 RA in patients with IBD and obesity and/or T2D is significantly associated with weight loss and a reduced risk for surgery.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/glp-1-ra-may-cut-surgery-risk-patients-ibd-2025a1000u4e?src=rss
Author :
Publish date : 2025-11-03 13:03:00
Copyright for syndicated content belongs to the linked Source.
